We are a technology-based company founded in 2015 with the proposal of offer innovative biotechnological solutions. Microbiotec was created with the objective to transform the basic knowledge generated at the university into commercial products for the national market. The company was conceived by two researchers from the Federal University of Viçosa (UFV) who have accumulated experience and scientific production of great impact in the area of microbiology, immunology and applied biotechnology for almost 20 years. Currently, Microbiotec’s controlling shareholder is Pensabio Instrumentos de Biotecnologia EIRELI, a well-established company in the field of Life Sciences with eight years of existence in the market.
In this new moment, Microbiotec looks for the industrialization and the commercialization of bacteriophage based products for different applications by means of industrial partnerts that leads in the market.
Our value proposition is to offer 100% national, low-cost, environmentally clean and efficient solutions for the diagnosis and control of undesirable bacteria in industry, human and animal health.
Acceleration Program at Biotechtown.
Bidded to provide services in the field of molecular microbiology.
Incubation at TecnoPARQ/Centev. Submission for park resident.
Pensabio buys 51% of Microbiotec’s shares. New business and investment model.
Create innovative biotechnological solutions for a sustainable social, economic and technological development.
Be a pioneer company in this country, offering high-tech solutions for bacterial control in different spheres of the production chain.
Commitment to the creation of sustainable products and services, with quality and high performance. Always innovate in search of disruptive solutions.